X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1713) 1713
Book / eBook (3) 3
Publication (3) 3
Book Chapter (2) 2
Conference Proceeding (2) 2
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1320) 1320
humans (1317) 1317
cholesterol (668) 668
proprotein convertase 9 (664) 664
male (630) 630
female (551) 551
pcsk9 (542) 542
hypercholesterolemia (473) 473
cholesterol, ldl - blood (464) 464
animals (444) 444
middle aged (423) 423
cardiac & cardiovascular systems (382) 382
low density lipoproteins (370) 370
lipids (354) 354
proprotein convertase 9 - antagonists & inhibitors (337) 337
familial hypercholesterolemia (335) 335
statins (331) 331
serine endopeptidases - genetics (309) 309
atherosclerosis (302) 302
subtilisin/kexin type 9 (300) 300
proprotein convertase subtilisin/kexin type 9 (297) 297
mice (280) 280
risk factors (263) 263
aged (261) 261
adult (256) 256
monoclonal-antibody (256) 256
anticholesteremic agents - therapeutic use (250) 250
hypercholesterolemia - drug therapy (249) 249
cardiovascular disease (248) 248
lipoproteins (244) 244
serine endopeptidases - metabolism (241) 241
mutation (238) 238
proprotein convertases (238) 238
receptors, ldl - metabolism (235) 235
density-lipoprotein cholesterol (232) 232
proprotein convertase 9 - metabolism (232) 232
biochemistry & molecular biology (230) 230
peripheral vascular disease (230) 230
ldl cholesterol (222) 222
antibodies, monoclonal - therapeutic use (217) 217
pharmacology & pharmacy (213) 213
treatment outcome (206) 206
heterozygous familial hypercholesterolemia (200) 200
receptors, ldl - genetics (192) 192
cardiovascular (190) 190
proprotein convertase 9 - genetics (182) 182
kexin (179) 179
mutations (179) 179
proprotein convertases - genetics (179) 179
safety (178) 178
low density lipoprotein (176) 176
proprotein convertase subtilisin (176) 176
efficacy (175) 175
proprotein convertases - metabolism (174) 174
subtilisin (174) 174
ldl receptor (172) 172
proprotein convertases - antagonists & inhibitors (171) 171
biomarkers - blood (170) 170
cardiovascular diseases (170) 170
coronary-heart-disease (170) 170
risk (169) 169
abridged index medicus (165) 165
autosomal-dominant hypercholesterolemia (165) 165
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (164) 164
monoclonal antibodies (162) 162
kexin type 9 (156) 156
research (156) 156
double-blind (148) 148
ldl (144) 144
analysis (143) 143
genetic aspects (143) 143
hyperlipoproteinemia type ii - genetics (143) 143
serine endopeptidases - blood (143) 143
endocrinology & metabolism (139) 139
density-lipoprotein receptor (135) 135
expression (134) 134
evolocumab (133) 133
metabolism (131) 131
alirocumab (130) 130
statin therapy (129) 129
degradation (128) 128
proprotein convertase 9 - blood (128) 128
proteins (128) 128
reducing lipids (128) 128
cardiovascular diseases - prevention & control (125) 125
hypercholesterolemia - blood (125) 125
liver (123) 123
disease (115) 115
medicine, general & internal (112) 112
care and treatment (111) 111
cholesterol - blood (109) 109
health aspects (109) 109
ldl-cholesterol (108) 108
ezetimibe (106) 106
low-density lipoprotein cholesterol (106) 106
anticholesteremic agents - adverse effects (104) 104
cholesterol, ldl - metabolism (104) 104
proprotein convertases - blood (102) 102
cardiovascular-disease (101) 101
dyslipidemias - drug therapy (101) 101
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1683) 1683
German (25) 25
Japanese (12) 12
Spanish (12) 12
Portuguese (3) 3
Russian (3) 3
Chinese (2) 2
French (2) 2
Czech (1) 1
Danish (1) 1
Korean (1) 1
Polish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 07/2015, Volume 163, Issue 1, pp. 40 - 51
Journal Article
Circulation, ISSN 0009-7322, 10/2015, Volume 132, Issue 17, pp. 1648 - 1666
Proprotein convertase subtilisin/kexin type 9 (PCSK9) plays an important role in the regulation of cholesterol homeostasis... 
Antibodies, monoclonal | Clinical trial | PCSK9 protein, human | antibodies, monoclonal | clinical trial | CARDIAC & CARDIOVASCULAR SYSTEMS | LOWERING THERAPY | MONOCLONAL-ANTIBODY | DENSITY-LIPOPROTEIN-CHOLESTEROL | HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA | DOUBLE-BLIND | PERIPHERAL VASCULAR DISEASE | STATIN-INTOLERANT PATIENTS | HEALTHY-VOLUNTEERS | CORONARY-HEART-DISEASE | PLASMA LDL CHOLESTEROL | PCSK9 GENE | Proprotein Convertases - antagonists & inhibitors | Cardiovascular Diseases - prevention & control | Humans | Serine Endopeptidases - physiology | Antibodies, Monoclonal - therapeutic use | Intestines - metabolism | Structure-Activity Relationship | Cardiovascular Diseases - enzymology | Molecular Targeted Therapy | Cardiovascular Diseases - genetics | Proprotein Convertases - genetics | Incidence | Brain - metabolism | RNA Interference | Oligonucleotides, Antisense - therapeutic use | Serine Endopeptidases - genetics | Cardiovascular Diseases - epidemiology | Protein Structure, Tertiary | Genetic Predisposition to Disease | Antibodies, Monoclonal, Humanized - therapeutic use | Serine Endopeptidases - deficiency | Liver - metabolism | Receptors, LDL - metabolism | Serine Endopeptidases - chemistry | Clinical Trials as Topic | Proprotein Convertases - chemistry | Proprotein Convertases - deficiency | Proprotein Convertases - physiology | Animals | RNA, Small Interfering - therapeutic use | Adipocytes - metabolism | Cholesterol, LDL - metabolism | Hyperlipoproteinemias - genetics | Mice | Peptide Fragments - therapeutic use | Mutation | Proprotein Convertase 9 | Monoclonal antibodies | Clinical trials | Usage | Care and treatment | Dosage and administration | Cardiovascular diseases
Journal Article
Atherosclerosis, ISSN 0021-9150, 2014, Volume 236, Issue 1, pp. 54 - 61
Journal Article
Diabetes, obesity & metabolism, ISSN 1462-8902, 2018, Volume 20, Issue 6, pp. 1391 - 1398
Journal Article
Journal Article
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2014, Volume 383, Issue 9911, pp. 60 - 68
Summary Background Proprotein convertase subtilisin/kexin type 9 (PCSK9) binds to LDL receptors, leading to their degradation... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | DENSITY-LIPOPROTEIN CHOLESTEROL | DOUBLE-STRANDED-RNA | PLASMA-CHOLESTEROL | METAANALYSIS | CARDIOVASCULAR-DISEASE | MONOCLONAL-ANTIBODY | HYPERCHOLESTEROLEMIA | STATINS | AMG 145 | ATORVASTATIN | Single-Blind Method | Serine Endopeptidases - biosynthesis | Humans | Middle Aged | RNA, Small Interfering - pharmacology | RNA, Small Interfering - adverse effects | Cholesterol, LDL - drug effects | Male | Healthy Volunteers | Proprotein Convertases - genetics | Dose-Response Relationship, Drug | Proprotein Convertases - biosynthesis | RNA Interference | Serine Endopeptidases - blood | Serine Endopeptidases - genetics | Adult | Cholesterol, LDL - blood | Female | Proprotein Convertases - blood | RNA, Small Interfering - administration & dosage | Genetic Therapy - adverse effects | Genetic Therapy - methods | Proprotein Convertase 9 | Enzymes | Research | Gene mutations | Properties | Gene expression | Identification and classification | Medical research | RNA | Low density lipoproteins | Anticholesteremic agents | Clinical trials | Aluminum compounds | Coronary heart disease | Cholesterol | Hypercholesterolemia | Analysis | Medicine, Experimental | Product development | Trans fatty acids | Blood proteins | Studies | Heart | Nanoparticles | Plasma | Nutrition research | Cardiovascular disease | Lipids | Mutation | Drug dosages | Statins
Journal Article
Circulation, ISSN 0009-7322, 08/2013, Volume 128, Issue 9, pp. 962 - 969
Journal Article
Journal Article
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 05/2017, Volume 57, Issue 5, pp. 616 - 626
Journal Article